Omada Health (NASDAQ:OMDA) Price Target Raised to $28.00 at Evercore ISI

Omada Health (NASDAQ:OMDA) had its price target boosted by Evercore ISI from $27.00 to $28.00 in a research note published on Friday,Benzinga reports. The brokerage currently has an outperform rating on the stock.

Other research analysts have also recently issued research reports about the stock. Weiss Ratings restated a “sell (d)” rating on shares of Omada Health in a report on Wednesday, October 8th. Robert W. Baird started coverage on shares of Omada Health in a research note on Friday, September 5th. They set a “neutral” rating and a $24.00 price objective for the company. Needham & Company LLC raised their price objective on Omada Health from $26.00 to $28.00 and gave the company a “buy” rating in a report on Friday. Barclays lifted their target price on Omada Health from $24.00 to $28.00 and gave the company an “overweight” rating in a research report on Wednesday, October 22nd. Finally, Baird R W raised Omada Health to a “hold” rating in a research report on Friday, September 5th. Seven investment analysts have rated the stock with a Buy rating, two have given a Hold rating and one has assigned a Sell rating to the company. According to data from MarketBeat, Omada Health presently has a consensus rating of “Moderate Buy” and an average target price of $26.25.

Omada Health Stock Performance

Omada Health stock traded down $1.56 during midday trading on Friday, reaching $20.31. The stock had a trading volume of 1,749,606 shares, compared to its average volume of 439,663. The company’s fifty day moving average is $23.70. Omada Health has a 1-year low of $14.14 and a 1-year high of $28.40.

Omada Health (NASDAQ:OMDA) last issued its quarterly earnings results on Thursday, August 7th. The company reported ($0.22) earnings per share for the quarter, missing the consensus estimate of ($0.15) by ($0.07). The firm had revenue of $61.37 million for the quarter, compared to the consensus estimate of $55.17 million.

Institutional Investors Weigh In On Omada Health

A number of institutional investors and hedge funds have recently modified their holdings of the company. Emerald Advisers LLC acquired a new position in Omada Health during the second quarter worth approximately $5,089,000. Emerald Mutual Fund Advisers Trust bought a new position in shares of Omada Health during the 2nd quarter worth approximately $2,950,000. Jennison Associates LLC bought a new position in shares of Omada Health during the 2nd quarter worth approximately $4,580,000. Sanofi acquired a new position in shares of Omada Health during the 2nd quarter worth approximately $9,606,000. Finally, Teacher Retirement System of Texas bought a new stake in Omada Health in the 2nd quarter valued at $640,000.

Omada Health Company Profile

Omada’s mission is to bend the curve. Our hope is that, one day, tomorrow’s epidemiologists will notice a bend in disease curves, wonder what might be happening, and conclude that part of that impact has been Omada. As part of that mission, we strive to inspire and enable people to make lasting health changes on their own terms.